Lv7
4980 积分 2021-03-01 加入
银屑病治疗指南和治疗目标的历史演变
4天前
已完结
Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome
14天前
已完结
60 mg dose ticagrelor provides stronger platelet inhibition than clopidogrel in Chinese patients with chronic coronary syndrome: A randomized, single-blind, crossover study
14天前
已完结
Inclisiran for LDL-C reduction in secondary prevention: Real-world evidence from a homogeneous Spanish cohort with subgroup insights
28天前
已完结
老年心血管病多学科诊疗共识
29天前
已完结
Bimekizumab versus Secukinumab in Plaque Psoriasis
1个月前
已完结
Bimekizumab versus Adalimumab in Plaque Psoriasis
1个月前
已完结
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
1个月前
已完结
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
1个月前
已完结
Residual cardiovascular risk: When should we treat it?
1个月前
已完结
皖公网安备34019202002308
